Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Shawn, Cazzell"'
Autor:
Robert J Snyder, John C Lantis, Alexander M. Reyzelman, Lawrence A. Lavery, Carl C Van Gils, Joseph M. Caporusso, Felix Sigal, Shawn Cazzell, Dean Vayser
Publikováno v:
Journal of Wound Care. 30:S18-S27
Aim: The purpose of this clinical trial was to evaluate the safety and efficacy of a fetal bovine acellular dermal matrix (FBADM) plus standard of care (SOC) for treating hard-to-heal diabetic foot ulcers (DFUs). Method: A prospective, multi-centre,
Publikováno v:
Scopus-Elsevier
Aim: Skin substitutes are frequently used to treat chronic diabetic foot ulcers (DFU), and many different options are available. While the clinical efficacy of many products has been evaluated, a comprehensive cost-effectiveness analysis comparing th
Autor:
Jason R. Hanft, Patrick S. Agnew, Joseph M. Caporusso, William Tettelbach, Felix Sigal, Shawn Cazzell, Cyaandi Dove
Publikováno v:
International Wound Journal
The aim of this study was to determine the safety and effectiveness of dehydrated human umbilical cord allograft (EpiCord) compared with alginate wound dressings for the treatment of chronic, non-healing diabetic foot ulcers (DFU). A multicentre, ran
Autor:
William Tettelbach, Patrick S. Agnew, Alexander M. Reyzelman, Shawn Cazzell, Joseph M. Caporusso, Felix Sigal
Publikováno v:
International Wound Journal
A randomised, controlled multicentre clinical trial was conducted at 14 wound care centres in the United States to confirm the efficacy of dehydrated human amnion/chorion membrane allograft (dHACM) for the treatment of chronic lower extremity ulcers
Autor:
Maria A Kasper, Brian D O'Carroll, Alexander M. Reyzelman, Joel M Neutel, Gabriel J Halperin, Shawn Cazzell, Douglas J Pacaccio
Publikováno v:
Journal of Wound Care. 27:S28-S37
Objective: To evaluate the safety and efficacy of a chorioamniotic allograft, used as a wound cover for chronic foot ulcers, in patients with diabetes. Methods: A multicentre, prospective, postmarket study where eligible patients received up to 11 we
Autor:
Alexander M. Reyzelman, Dean Vayser, Gregory Tovmassian, Shawn Cazzell, Hasan Dosluoglu, Christian Bianchi
Publikováno v:
International Wound Journal. 15:114-122
A randomised, controlled, multicentre clinical trial was conducted to evaluate the efficacy of dehydrated human amnion/chorion membrane (EpiFix) allograft as an adjunct to multilayer compression therapy for the treatment of non-healing full-thickness
Feasibility and Efficacy of a Smart Mat Technology to Predict Development of Diabetic Plantar Ulcers
Autor:
Ian L. Gordon, Bijan Najafi, Alexander M. Reyzelman, Brian J. Petersen, Aksone Nouvong, Gary M. Rothenberg, David R. Linders, Jonathan D. Bloom, Shawn Cazzell, Ryan H Fitzgerald, Robert G. Frykberg
Publikováno v:
Diabetes Care. 40:973-980
OBJECTIVE We conducted a multicenter evaluation of a novel remote foot-temperature monitoring system to characterize its accuracy for predicting impending diabetic foot ulcers (DFU) in a cohort of patients with diabetes with previously healed DFU. RE
Autor:
Alexander M. Reyzelman, Kimberly Dorsch, Dean Vayser, Hau Pham, Mark A. Moore, Shawn Cazzell, Brian Samsell, Jodi Walters
Publikováno v:
Wound Repair and Regeneration. 25:483-497
This study compared the efficacy and safety of a human acellular dermal matrix (ADM), D-ADM, with a conventional care arm and an active comparator human ADM arm, GJ-ADM, for the treatment of chronic diabetic foot ulcers. The study design was a prospe
Publikováno v:
Advances in Skin & Wound Care
OBJECTIVE This prospective, multicenter study evaluated the efficacy and safety of an acellular dermal matrix allograft, DermACELL (D-ADM; LifeNet Health, Virginia Beach, Virginia), in the treatment of large, complex diabetic foot ulcers (DFUs) that
Autor:
Shawn, Cazzell
Publikováno v:
Wounds : a compendium of clinical research and practice. 31(3)
Venous leg ulcers (VLUs) are often chronic and difficult to treat, which makes alternative options to conventional care necessary to improve ulcer healing rates. While human acellular dermal matrices (ADMs) have shown promise in treating diabetic foo